The International Society for Stem Cell Research (ISSCR) welcomes the finding of the U.S. Court of Appeals for the District of Columbia upholding an earlier dismissal of Sherley v Sebelius, a court case that had challenged federal funding of human embryonic stem cell research. This latest ruling reaffirms the ability of the U.S. National Institutes of Health to fund research using human embryonic stem cells under the policies described in their Guidelines for Human Stem Cell Research (July 7, 2009).
The ISSCR supports all forms of stem cell research – employing human embryonic stem cells, induced pluripotent stem cells, umbilical cord blood stem cells and somatic (adult) stem cells – that adhere to international standards of scientific conduct including the ISSCR Guidelines for Human Embryonic Stem Cell Research (2006). All are essential to advancing our understanding of human health and disease. Embryonic stem cell research has been a groundbreaking area of scientific and medical discovery in the past 10 years. Funding rigorous and meritorious research ensures that the best ideas are supported and that the public benefits from medical advances.
“This ruling has important implications for both patients and scientists, and it represents a major step towards ensuring that all forms of scientifically and medically appropriate stem cell research are deployed in the fight against terrible human diseases,” says ISSCR President Shinya Yamanaka.
Read the Court decision, August 24, 2012
The International Society for Stem Cell Research is an independent, nonprofit membership organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research and application.